Cargando…
Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain
Antipsychotic drugs (AP) are used to treat a multitude of psychiatric conditions including schizophrenia and bipolar disorder. However, APs also have metabolic side effects including increased food intake and body weight, but the underlying mechanisms remain unknown. We previously reported that mino...
Autores principales: | Zapata, Rizaldy C., Rosenthal, Sara Brin, Fisch, Kathleen, Dao, Khoi, Jain, Mohit, Osborn, Olivia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596057/ https://www.ncbi.nlm.nih.gov/pubmed/33122657 http://dx.doi.org/10.1038/s41598-020-75624-2 |
Ejemplares similares
-
Conserved immunomodulatory transcriptional networks underlie antipsychotic-induced weight gain
por: Zapata, Rizaldy C., et al.
Publicado: (2021) -
Antipsychotic-induced weight gain and metabolic effects show diurnal dependence and are reversible with time restricted feeding
por: Zapata, Rizaldy C., et al.
Publicado: (2022) -
Adipocytes control food intake and weight regain via Vacuolar-type H(+) ATPase
por: Zapata, Rizaldy C., et al.
Publicado: (2022) -
Targeting Clic1 for the treatment of obesity: A novel therapeutic strategy to reduce food intake and body weight
por: Zapata, Rizaldy C., et al.
Publicado: (2023) -
S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)